MA55891A - Synthèses en phase liquide convergente d'oligonucléotides - Google Patents
Synthèses en phase liquide convergente d'oligonucléotidesInfo
- Publication number
- MA55891A MA55891A MA055891A MA55891A MA55891A MA 55891 A MA55891 A MA 55891A MA 055891 A MA055891 A MA 055891A MA 55891 A MA55891 A MA 55891A MA 55891 A MA55891 A MA 55891A
- Authority
- MA
- Morocco
- Prior art keywords
- oligonucleotides
- liquid phase
- phase syntheses
- convergent
- convergent liquid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/02—Phosphorylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962845160P | 2019-05-08 | 2019-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA55891A true MA55891A (fr) | 2022-03-16 |
Family
ID=70919104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA055891A MA55891A (fr) | 2019-05-08 | 2020-05-08 | Synthèses en phase liquide convergente d'oligonucléotides |
Country Status (13)
Country | Link |
---|---|
US (1) | US20220348602A1 (fr) |
EP (1) | EP3966219A2 (fr) |
JP (1) | JP2022531876A (fr) |
KR (1) | KR20220007104A (fr) |
CN (1) | CN114206897A (fr) |
AU (1) | AU2020268415A1 (fr) |
BR (1) | BR112021022219A2 (fr) |
CA (1) | CA3139545A1 (fr) |
EA (1) | EA202193010A1 (fr) |
IL (1) | IL287798A (fr) |
MA (1) | MA55891A (fr) |
MX (1) | MX2021013587A (fr) |
WO (1) | WO2020227618A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013203395A1 (en) | 2012-03-30 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulating TAU expression for reducing seizure and modifying a neurodegenerative syndrome |
WO2022103842A1 (fr) | 2020-11-11 | 2022-05-19 | Biogen Ma Inc. | Oligonucléotides, réactifs et préparation associée |
AU2022314802A1 (en) * | 2021-07-23 | 2024-02-08 | Biogen Ma Inc. | Methods for reducing tau expression |
WO2024083746A1 (fr) | 2022-10-17 | 2024-04-25 | Bachem Holding Ag | Procédé et composition pour la synthèse d'oligonucléotides |
JP7433684B1 (ja) | 2023-05-24 | 2024-02-20 | 塩野フィネス株式会社 | 疑似固相保護基、それを用いたヌクレオシド保護体又はオリゴヌクレオチド保護体、オリゴアミダイト前駆体の製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0558749A1 (fr) * | 1990-11-20 | 1993-09-08 | Sankyo Company Limited | Derives d'acide nucleique non codant |
US5510476A (en) * | 1994-07-07 | 1996-04-23 | Isis Pharmaceuticals, Inc. | Carbocation scavenging during oligonucleotide synthesis |
SI2548560T1 (sl) | 2005-06-23 | 2015-12-31 | Isis Pharmaceuticals, Inc. | Sestavki in postopki za moduliranje izrezovanja smn2 |
HUE046966T2 (hu) | 2009-06-17 | 2020-04-28 | Biogen Ma Inc | Készítmények és módszerek az SMN2 splicing egy alanynál történõ modulálására |
DK2711370T3 (en) * | 2011-05-17 | 2018-02-26 | Ajinomoto Kk | PROCEDURE FOR THE PREPARATION OF OLIGONUCLEOTIDES |
JP6237237B2 (ja) * | 2012-02-17 | 2017-11-29 | 味の素株式会社 | 塩基部保護オリゴヌクレオチド |
US8846885B2 (en) * | 2012-02-17 | 2014-09-30 | Ajinomoto Co., Inc. | Oligonucleotide with protected base |
IN2014DN10144A (fr) * | 2012-05-30 | 2015-08-21 | Hokkaido System Science Co Ltd | |
EP4137573A3 (fr) | 2014-04-01 | 2023-05-03 | Biogen MA Inc. | Compositions pour moduler l'expression de sod-1 |
JP7027889B2 (ja) * | 2015-12-16 | 2022-03-02 | 味の素株式会社 | オリゴヌクレオチドの製造方法、およびヌクレオシド、ヌクレオチドまたはオリゴヌクレオチド |
JPWO2017111137A1 (ja) * | 2015-12-22 | 2018-10-18 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
-
2020
- 2020-05-08 EA EA202193010A patent/EA202193010A1/ru unknown
- 2020-05-08 EP EP20729413.3A patent/EP3966219A2/fr active Pending
- 2020-05-08 WO PCT/US2020/032070 patent/WO2020227618A2/fr unknown
- 2020-05-08 BR BR112021022219A patent/BR112021022219A2/pt unknown
- 2020-05-08 CN CN202080044020.2A patent/CN114206897A/zh active Pending
- 2020-05-08 AU AU2020268415A patent/AU2020268415A1/en active Pending
- 2020-05-08 CA CA3139545A patent/CA3139545A1/fr active Pending
- 2020-05-08 MX MX2021013587A patent/MX2021013587A/es unknown
- 2020-05-08 JP JP2021565931A patent/JP2022531876A/ja active Pending
- 2020-05-08 US US17/608,802 patent/US20220348602A1/en active Pending
- 2020-05-08 KR KR1020217039894A patent/KR20220007104A/ko active Search and Examination
- 2020-05-08 MA MA055891A patent/MA55891A/fr unknown
-
2021
- 2021-11-02 IL IL287798A patent/IL287798A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020227618A8 (fr) | 2020-12-24 |
US20220348602A1 (en) | 2022-11-03 |
IL287798A (en) | 2022-01-01 |
MX2021013587A (es) | 2022-02-11 |
EA202193010A1 (ru) | 2022-03-18 |
WO2020227618A3 (fr) | 2021-01-14 |
AU2020268415A8 (en) | 2022-01-20 |
JP2022531876A (ja) | 2022-07-12 |
EP3966219A2 (fr) | 2022-03-16 |
CA3139545A1 (fr) | 2020-11-12 |
AU2020268415A1 (en) | 2021-12-23 |
BR112021022219A2 (pt) | 2022-03-22 |
KR20220007104A (ko) | 2022-01-18 |
WO2020227618A2 (fr) | 2020-11-12 |
CN114206897A (zh) | 2022-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA55891A (fr) | Synthèses en phase liquide convergente d'oligonucléotides | |
MA51066A (fr) | Inhibiteurs d'intégrine | |
MA54547A (fr) | Amides d'hétéroaryle utiles en tant qu'inhibiteurs de kif18a | |
MA46905A (fr) | Compositions et procédés de synthèse de phosphoramidites et d'oligonucléotides | |
MA43822A (fr) | Compositions et procédés de synthèse de phosphoramidite et d'oligonucléotides | |
FR3046038B1 (fr) | Module de support de sac a dos pour une structure modulaire d'exosquelette | |
MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
MA51795A (fr) | Oligonucléotides pour moduler l'expression de tmem106b | |
FR3009688B1 (fr) | Pulverisateur d'un produit de revetement liquide et installation de pulverisation comprenant un tel pulverisateur | |
MA54713A (fr) | Forme posologique parentérale stable d'acétate de cétrorélix | |
MA39500A (fr) | Compositions à base d'extraits de plantes pour l'inhibition de la 5-alpha-réductase | |
MA53392A (fr) | Formulation agrochimique liquide stable | |
MA49278A (fr) | Oligonucléotides antisens pour moduler l'expression de htra1 | |
MA53648A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase | |
IT201900024847A1 (it) | Erogatore di prodotto sfuso | |
MA54692A (fr) | Composition pour l'agriculture anti-pathogènes liquide | |
FR3005263B1 (fr) | Composition pharmaceutique ou dietetique liquide ou semi-liquide depourvue d'amertume contenant un sel d'arginine. | |
MA48445A (fr) | Distributeur destiné à la distribution d'un agent chimique à partir d'un récipient couplé au distributeur | |
JP1737720S (ja) | 液体注出具 | |
JP1737719S (ja) | 液体注出具 | |
FR3034980B1 (fr) | Paillette pour la conservation d'une dose predeterminee de substance a base liquide | |
JP1764154S (ja) | 石鹸またはシャンプー用ディスペンサー | |
UA42371S (uk) | Інтер'єр прикасової зони ломбарду | |
JP1769815S (ja) | シャンプーディスペンサー土台 | |
DK3866655T3 (da) | Væskedispenser |